March 4, 2024



Novavax’s COVID vaccine becomes the fifth jab to be approved for use in the EU


By Euronews  with AFP

Novavax’s COVID vaccine has become the fifth to be authorised for use in the European Union.

It was given the green light by the European Commission after the European Medicines Agency (EMA) recommended it for use on Monday.

“We welcome today’s European Commission decision reflecting the first authorization of a protein-based COVID-19 vaccine for the people of the E.U.,” said Stanley C. Erck, Novavax’s CEO.

Read more…